WhiteOak Capital Mutual FundHealthcareDirect plan, growth

WhiteOak Capital Pharma and Healthcare Fund

Compare healthcare funds Compare with others

NAV: ₹17.76; —11 Sept 2026
AUM (₹ Cr): 642; Average, April - June 2026
Expense ratio: 1.09%; Regular 2.76%
Risk: Very High; SEBI riskometer

1Y return: 22.7%+7.2%; Benchmark 15.5%
3Y CAGR: —; Category 21.7%
5Y CAGR: —; Category 15.6%

Loading NAV history…

WhiteOak Capital Pharma and Healthcare Fund

Calendar-year returns

Fund only: no comparison series covers this fund's history.

Risk statistics

Five years of daily NAVs. Risk-free rate 6.5% a year.

Standard deviation: —
Maximum drawdown: —
Sharpe ratio: —
Sortino ratio: —
Beta: —
Alpha: —
R²: —
Information ratio: —
Upside capture: —
Downside capture: —
Tracking error: —

Trailing returns compared with benchmark
Period	1M	3M	6M	YTD	1Y	3YCAGR	5YCAGR	10YCAGR	LaunchCAGR
Fund	+0.7%	+11.3%	+26.5%	+25.1%	+22.7%	—	—	—	+24.4%
BSE Healthcare TRI	—	—	—	—	15.5%	—	—	—	17.0%
Healthcare average	0.3%	9.6%	22.5%	20.0%	17.6%	21.7%	15.6%	15.0%	19.1%
Difference	—	—	—	—	+7.2%	—	—	—	+7.4%

Portfolio

Fund details

Fund house: WhiteOak Capital Mutual Fund
Category: Equity · Healthcare
SEBI classification: Equity / Sectoral / Thematic
Benchmark: BSE Healthcare TRI
Launch date: 7 Feb 2024 (2.6 years)
Structure: Open Ended
Plans and options: Direct Growth, Regular Growth
Fund manager: Ramesh Mantri
Minimum SIP: ₹100
Minimum lumpsum: ₹500 (then ₹500)
Exit load: None
Lock-in: None
Riskometer: Very High (benchmark Very High)
Expense ratio as of: 9 Sept 2026
AUM period: April - June 2026
ISIN, Direct Growth: INF03VN01886
ISIN, Regular Growth: INF03VN01878
Scheme code: 152349, 152348

NAV and returns as of 11 Sept 2026; returns are for the direct plan, growth option, before entry or exit costs. Not investment advice.

Other healthcare funds

Other funds in the Healthcare category.

Compare healthcare funds